March 3 (Reuters) - Rapid Micro Biosystems Inc RPID.O :
* RAPID MICRO BIOSYSTEMS REPORTS FOURTH QUARTER AND FULL
YEAR 2022
FINANCIAL RESULTS AND PROVIDES FULL YEAR 2023 GUIDANCE
* TOTAL REVENUE FOR Q4 OF 2022 WAS $4.4 MILLION, COMPARED TO
$5.2
MILLION IN Q4 OF 2021
* FOR FULL YEAR 2023, COMPANY EXPECTS COMMERCIAL REVENUE OF
AT
LEAST $22.0 MILLION
* NET LOSS PER SHARE ATTRIBUTABLE TO COMMON SHAREHOLDERS FOR
Q4 OF
2022 WAS $0.39
* Q4 EARNINGS PER SHARE VIEW $-0.36, REVENUE VIEW $4.5
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6bSY5d
Further company coverage: RPID.O
((Reuters.Briefs@thomsonreuters.com;))